More results...

Therapeutics Areas
Learner Specialties
Expires After
  • On-Demand
Recognizing the Profound Impact on Quality of Life: Emerging Therapy Options for Patients with Myelofibrosis
  • Credit: 1.00hr(s)
  • ILNA, NCPD
  • July 15, 2024 — 
  • July 14, 2025
  • Specialties: Hematology, Myelofibrosis, Oncology
  • Location: Internet Activity Enduring
In on-demand activity, Recognizing the Profound Impact on Quality of Life: Emerging Therapy Options for Patients with Myelofibrosis, learn from expert faculty, Jeanne Palmer, MD and Jennifer Andres, APRN, FNP, MSN as they discuss Profound Impact on Quality of Life: Emerging Therapy Options for Patients with Myelofibrosis, to effectively identify how JAK inhibitors and emerging treatments for myelofibrosis (MF) can optimize clinical outcomes and patient quality of life (QOL). Gain expert insights from enduring online program focuses on patient risk and drug mechanisms of action for effective treatment and management, gaps in MF care that influence patient QOL, disease- and treatment-related adverse events, trust with patients to improve outcomes and QOL, as well as shared decision-making and the unique role of multidisciplinary teams.
Access Course
  • On-Demand
Impact of Prevention: Updates in Vaccine Development
  • Credit: 0.50hr(s)
  • AAFP, AAPA, ABIM, CME, IPCE, MOC, NCPD, Royal College MOC 
  • June 28, 2024 — 
  • June 27, 2025
  • Therapeutic Areas: Family Medicine / Primary Care
  • Specialties: Primary Care
  • Location: Internet Activity Enduring
Healthcare providers (HCPs) encounter significant challenges in vaccine acceptance. A critical need exists among primary care providers (PCPs) to remain abreast of the continuously evolving vaccination landscape. As such, PCPs need to be able to evaluate the burden of vaccine-preventable diseases, provide well-founded recommendations for vaccine measures, and apply appropriate strategies to address vaccine hesitations.
Access Course
  • On-Demand
New Horizons in Multiple Myeloma Treatment: The Promise of CAR-T for Early Relapsed Disease
  • Credit: 1.00hr(s)
  • AAPA, CME, CPE, IPCE, NCPD
  • May 31, 2023 — 
  • May 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: CAR T-Cell Therapy, Multiple Myeloma
  • Location: Internet Activity Enduring
Despite remarkable progress, significant gaps remain in meeting the needs of patients facing relapse in multiple myeloma, particularly among patients with early relapse or triple-class exposed disease. Join us for a groundbreaking Special Edition Med Table Talk episode where we delve into the latest advancements in the treatment of relapsed multiple myeloma (RRMM).  This candid conversation between esteemed faculty experts discusses the latest clinical evidence and rationale for CAR T-cell therapy in early versus late relapse settings and embraces a future pathway where highly effective treatments may be delivered earlier to support increasingly durable responses for complex patient populations.
Access Course
  • On-Demand
The Evolution of HCT, Part 3: Donor Availability
  • Credit: 0.75hr(s)
  • CME, NCPD
  • February 22, 2024 — 
  • February 20, 2025
  • Therapeutic Areas: Hematologic Oncology, Hematology, Hematopoietic Cell Transplantation (HCT), Oncology
  • Specialties: Bone Marrow Transplantation, Hematology, Oncology
  • Location: Internet Activity Enduring
Community hematology/oncology practices play a critical role to expand patient access to hematopoietic cell transplantation (HCT) and improve patient outcomes. This self-guided online training course series consists of five courses designed to present the current state of the science for Hematopoietic Cell Transplantation (HCT) by following the evolution of HCT over time. The series is broken down into major misperceptions or myths about HCT and cellular therapy that are not supported by current research and clinical practice. This is Part 3 in a 5-part series, covering advances in donor availability that have led to expanded access to HCT over time.
Access Course
  • On-Demand
Understanding the Impact of Weight on T2D Outcomes
  • Credit: 0.50hr(s)
  • AAFP, AAPA, ABIM, CME, IPCE, MOC
  • April 30, 2024 — 
  • October 31, 2025
  • Therapeutic Areas: Diabetes, Family Medicine / Primary Care, Obesity
  • Specialties: Diabetes, Endocrinology, Obesity, Primary Care
  • Location: Internet Activity Enduring
Healthcare providers (HCPs) encounter significant challenges when treating patients with type 2 diabetes (T2D). HCPs should be cognizant of when to change or intensify treatment and be aware of options that are non-optimal. As such, HCPs need to be equipped with current professional guidelines, the latest clinical evidence on new and emerging therapies for T2D, and strategies for engaging patients in shared decision-making to effectively prioritize weight management and promote comprehensive T2D care.
Access Course
  • On-Demand
The Evolution of HCT, Part 5: Shared Care
  • Credit: 0.75hr(s)
  • CME, NCPD
  • February 22, 2024 — 
  • February 20, 2025
  • Therapeutic Areas: Hematologic Oncology, Hematology, Hematopoietic Cell Transplantation (HCT), Oncology
  • Specialties: Bone Marrow Transplantation, Hematology, Oncology
  • Location: Internet Activity Enduring
Community hematology/oncology practices play a critical role to expand patient access to hematopoietic cell transplantation (HCT) and improve patient outcomes. This self-guided online training course series consists of five courses designed to present the current state of the science for Hematopoietic Cell Transplantation (HCT) by following the evolution of HCT over time. The series is broken down into major misperceptions or myths about HCT and cellular therapy that are not supported by current research and clinical practice. This is Part 5 in a 5-part series, exploring how shared and coordinated care between transplant centers and hematology/oncology practices can help overcome barriers to HCT and improve patient outcomes and experience.
Access Course
  • On-Demand
Metastatic Breast Cancer Retreats: Value to the Patient and Your Multidisciplinary Team
  • Credit: 0.50hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Why Your Patients Should Attend a Metastatic Breast Cancer Retreat and the Value it also provides to you and your multi-disciplinary team. This video will demonstrate some of the activities that take place at a MBC retreat and the lessons learned from them.
Access Course
  • On-Demand
Supporting the Family Caregiver
  • Credit: 0.50hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
The role of the treatment team in supporting the family caregiver. What you will learn from this module: Learn the physical and emotional needs of the caregiver managing the patient at home. Understand the stress and challenges loved ones face while caregiving. Realize that oftentimes the oncologist’s focus is solely on the patient and not on the loved one who is caregiving. Understand that a caregiver for a patient might be someone outside of the family- like a close friend. This can be due to the lack of family members, dysfunctional family dynamics, or ages of family members (young and old).
Access Course
  • On-Demand
Effective Strategies for Shared Decision-Making in T2D Care
  • Credit: 0.50hr(s)
  • AAFP, AAPA, ABIM, CME, IPCE, MOC
  • April 30, 2024 — 
  • October 31, 2025
  • Therapeutic Areas: Diabetes, Family Medicine / Primary Care, Obesity
  • Specialties: Diabetes, Endocrinology, Obesity, Primary Care
  • Location: Internet Activity Enduring
Healthcare providers (HCPs) encounter significant challenges when treating patients with type 2 diabetes (T2D). HCPs should be cognizant of when to change or intensify treatment and be aware of options that are non-optimal. As such, HCPs need to be equipped with current professional guidelines, the latest clinical evidence on new and emerging therapies for T2D, and strategies for engaging patients in shared decision-making to effectively prioritize weight management and promote comprehensive T2D care.
Access Course
  • On-Demand
The Importance of Being Honest
  • Credit: 0.25hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Of everything we do for our patients, the most important thing we can give them is honesty. What you will learn from this module: Learn that being honest with patients about their disease and its prognosis is very important for patients to know so they can plan out the remainder of their lives. Honesty doesn’t take away hope; it helps the patient move through phases of hope. 50% of the time, doctors do not disclose the patients’ actual prognosis. Patients do not understand or know the difference between palliative chemotherapy and active chemotherapy treatments, unless they are told.  Teaching patients to be optimistic for as long as it is realistic, while having an end of life plan in place should be our mantra. Avoidance of honesty may be linked to an oncologist’s feelings of believing they have failed the patient by not being able to save or sustain their life.
Access Course
  • On-Demand
Key Questions at Your Patient's First Consultation
  • Credit: 0.50hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Beyond the general questions routinely asked at the time of an initial consultation, there are additional thought provoking questions that will elicit answers that will be very informative and serve as a baseline for future discussions. Such questions need to be periodically asked again, during future visits, especially when decisions are being made around treatment options and/or end of life care.
Access Course
  • On-Demand
Making the Right Selection: Expert Guidance on Treatment Sequencing of T-cell Mediated Therapies
  • Credit: 0.50hr(s)
  • AAPA, ABIM, CME, CPE, MOC, NCPD, Royal College MOC 
  • May 15, 2024 — 
  • May 14, 2025
  • Therapeutic Areas: Pan Tumor, Pathology, Pharmacy
  • Specialties: Pathology, Pharmacy
  • Location: Internet Activity Enduring
In this second episode, “Making the Right Selection: Expert Guidance on Treatment Sequencing of T-cell Mediated Therapies,” from the 4-part series Med Table Talk, “The Power of the Community: Translating Innovations into Care in NHL and HL,” learn from expert faculty on how to select CAR T-cell and bispecific antibody treatment regimens for NHL according to the latest clinical evidence including safety and efficacy data in accordance with clinical guidelines. Additionally, expert faculty will discuss how to best identify patients who are candidates for CAR T-cell or bispecific antibody therapies as well as how to evaluate the potential of bridging therapy in patients awaiting CAR T-cell therapy. Finally, expert faculty will review treatment-related toxicities with strategies and educational tools that can be used to prevent, monitor, and manage adverse events. This episode will conclude with a discussion between expert faculty and a special guest, Caitlin Murphy, DNP.
Access Course
  • On-Demand
Beyond Inertia: Advancing T2D Care With Innovative Basal Insulin Strategies
  • Credit: 1.50hr(s)
  • CME, CPE, NCPD, PA
  • June 21, 2024 — 
  • June 20, 2025
  • Therapeutic Areas: Diabetology, Endocrinology
  • Specialties: Endocrinology, Primary Care
  • Location: Internet Activity Enduring
Discover the forefront of diabetes care at Diabetes Dialogues LIVE, targeting the latest in once-weekly basal insulin therapy, including unique mechanism of action and pharmacokinetic/pharmacodynamic properties. Join fellow endocrinologists to unpack recent safety and efficacy data. Additionally, hear discussion about basal insulin therapy for patient care and how to best ensure adherence through effective T2D management. Delve into clinical trials outcomes, glycemic control, weight management, and hypoglycemia risks. Engage in essential scientific discourse to shape the future of diabetes treatment. Do not miss this event for an insightful blend of data and practice. This activity is derived from the Live ISS Meeting at ENDO, originally held on June 1, 2024.
Access Course
  • On-Demand
Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health - Screening and Management of OSA
  • Credit: 0.50hr(s)
  • AAFP, AAPA, CME, MOC
  • February 21, 2024 — 
  • February 20, 2025
  • Therapeutic Areas: Family Medicine / Primary Care
  • Location: Internet Activity Enduring
Obstructive Sleep Apnea (OSA) is a prevalent but often underestimated sleep disorder with significant implications for the health and well-being of individuals in the United States. Despite its impact on chronic diseases and healthcare costs, OSA remains underdiagnosed, leading to untreated sleep apnea and its consequences. With emerging strategies for OSA treatment, it’s crucial for healthcare providers to stay informed about the latest clinical evidence shaping the treatment landscape. Explore the 3-part on-demand series, Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health. This collaborative effort, in conjunction with local AAFP Chapter meetings, provides expert guidance and clinical best practices for screening, managing, monitoring, and treating patients with OSA
Access Course
  • On-Demand
Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disorders: Addressing Unmet Needs with Emerging Therapies
  • Credit: 1.00hr(s)
  • AAPA, CME, ILNA, IPCE, MOC
  • September 25, 2024 — 
  • September 24, 2025
  • Specialties: Epstein-Barr virus (EBV), Post-Transplant Lymphoproliferative Disorders (PTLD)
  • Location: Internet Activity Enduring
In this Hematology Dialogues, Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disorders: Addressing Unmet Needs with Emerging Therapies, participants will learn about the epidemiology and burden of Epstein-Barr Virus-positive (EBV+) and post-transplant lymphoproliferative disorders (PTLD), differentiate between current and emerging prognostic scoring systems for EBV+ and PTLD to inform treatment decisions, and evaluate the latest clinical evidence of emerging treatment options for EBV+ and PTLD. Experts will discuss hot topics in the field of EBV+ and PTLD as well as respond to patient cases and provide commentary relating to how they have responded to complex treatment decisions, thereby ensuring optimal clinical outcomes. This independent satellite symposium is derived from the Society of Hematologic Oncology 2024 Annual Meeting, originally held on September 5, 2024.
Access Course
  • On-Demand
Prognostic Factors
  • Credit: 0.25hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Educating patients about treatment and survival of metastatic breast cancer is strongly linked to the cancer’s prognostic factors. What you will learn from this module: Learn the importance of educating patients about their specific metastatic breast cancer, focusing on its prognostic factors. Be able to teach a patient how their breast cancer treatments and prognosis may be different from other metastatic breast cancer patients they meet. Determine the optimal way to provide this education so it is understood by your patient.
Access Course
  • On-Demand
Shared Decision Making
  • Credit: 0.50hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
It is a process that fosters shared decision making that includes exploring and comparing the benefits, harms, and risks of each health care option through meaningful dialogue about what matters most to the patient. The doctor and patient need to use evidence-based information while working together to make the best possible treatment decisions.
Access Course
  • On-Demand
The Value and Importance of Not Postponing Joy
  • Credit: 0.25hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Educating your advanced cancer patients about the value and importance of not postponing joy. There is a tendency to avoid discussing the future, too far in advance, with your patients with advanced disease. The sooner we bring up the topic of not postponing joy, the better however. Patients may even say that they are planning on a family vacation to Disney World in 2 years. Your thoughts immediately go to estimating when she will be likely too ill to go but may not be verbalizing this to her. You don’t want to take away hope and burst that bubble. It however isn’t fair to the patient to be assuming that no response from you regarding such an announcement, or worse, saying that this sounds great, is doing her an injustice. Additionally, though she may still be living in two years and technically able to go to Disney World, she may very well be spending her time in the hotel room and not enjoying herself and her children/grandchildren doing park activities. Her goal wasn’t to be in a bed too weak to partake of this important family adventure. This is why a discussion about “Don’t Postpone Joy” is so important. It fits for many clinical settings too.
Access Course
  • On-Demand
Overcoming Obesity: A PCP's Guide to Comprehensive Obesity Care
  • Credit: 1.50hr(s)
  • AAPA, ABIM, CME, MOC, NCPD
  • September 1, 2024 — 
  • August 31, 2025
  • Specialties: Primary Care
  • Location: Internet Activity Enduring
Addressing obesity in primary care remains a significant challenge, despite established evidence-based strategies and the introduction of new anti-obesity medications. Obstacles such as weight bias, stigma, and limited patient engagement in shared decision-making complicate effective weight management. With the growing array of therapeutic options for obesity, it is crucial for clinicians to adopt shared decision-making practices to improve treatment adherence, support patient goals, and foster holistic, patient-centered care. Join our engaging 3-part on-demand Community Collective Chapter Series, Overcoming Obesity: A PCP’s Guide to Comprehensive Obesity Care. This series, in collaboration with local AAFP Chapter meetings, equips learners with evidence-based approaches to screening, diagnosing, and treating obesity. Gain practical strategies for initiating weight management conversations with patients, incorporating shared decision-making to personalize treatment goals. Don’t miss this opportunity! Enroll now to gain valuable insights and elevate your practice in obesity care.
Access Course
  • On-Demand
Build Your Own Case Study | Redefining MASLD/MASH Care: Personalized Strategies for Assessment, Diagnosis and Management
  • Credit: 1.0hr(s)
  • AAPA, CME, EBAH, ECMEC, IPCE, MOC, NCPD
  • June 13, 2024 — 
  • June 12, 2025
  • Therapeutic Areas: Diabetes, Endocrinology
  • Specialties: Diabetes, Gastroenterology
  • Location: Internet Activity Enduring
Health Care Providers (HCPs) in the endocrinology specialty setting are challenged to be knowledgeable of the pathophysiology of MASLD (metabolic dysfunction-associated steatotic liver disease) and MASH (metabolic dysfunction-associated steatohepatitis) and its associated risk factors, as well as feel confident around how and when to order noninvasive diagnostic tests to prevent the emergence of more severe complications and stay on top of current guidelines and emerging treatment options.
Access Course
  • On-Demand
Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health - Improving Collaboration Amongst Multidisciplinary Teams to Tackle OSA
  • Credit: 0.50hr(s)
  • AAFP, AAPA, CME, MOC
  • March 6, 2024 — 
  • March 5, 2025
  • Therapeutic Areas: Family Medicine / Primary Care
  • Location: Internet Activity Enduring
Obstructive Sleep Apnea (OSA) is a prevalent but often underestimated sleep disorder with significant implications for the health and well-being of individuals in the United States. Despite its impact on chronic diseases and healthcare costs, OSA remains underdiagnosed, leading to untreated sleep apnea and its consequences. With emerging strategies for OSA treatment, it’s crucial for healthcare providers to stay informed about the latest clinical evidence shaping the treatment landscape.
Access Course
  • On-Demand
Delivering Patient Centered Care
  • Credit: 0.25hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Patient-centered care is a model of care that respects the patient’s experience, values, needs and preferences in the planning, coordination and delivery of care. A central component of this model is a therapeutic relationship between the patient and the team of healthcare professionals. The implementation of a patient-centered care model has been shown to contribute to improved outcomes for patients, better use of resources, decreased costs and increased satisfaction with care. This article provides an overview of the barriers to providing patient-centered care and identifies strategies that can be implemented to overcome them.
Access Course
  • On-Demand
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice / Activity 2
  • Credit: 0.50hr(s)
  • AAPA, CME, CPE, NCPD
  • February 17, 2023 — 
  • September 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Oncology
  • Specialties: NSCLC, Oncology
  • Location: Internet Activity Enduring
This educational initiative is designed for community-based oncology clinicians (physicians, nurse practitioners [NPs], physician assistants [PAs], pharmacists, and nurses) to enhance outcomes for individuals with who provide care for individuals with mNSCLC. This interactive online activity uses the game-based platform Kahoot! to test participant ability to identify and apply key learning points to metastatic NSCLC (mNSCLC) patient cases while competing against their colleagues. Expert faculty will discuss the emerging efficacy and safety data for CTLA-4 inhibitor combination regimens in mNSCLC and explore strategies to identify patients who would most benefit from these therapies through the use of biomarkers. Additionally, there will be an in-depth discussion regarding approaches to effectively collaborate with other clinicians and mNSCLC patients to provide cost-effective, equitable, and inclusive care for patients of all socioeconomic and racial/ethnic backgrounds. Join us for Part 1 of this question and answer based educational activity, Improving Survival in First-line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies for an in-depth dive into the data!
Access Course
  • On-Demand
Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health - The Interconnection of OSA and Disease-related Complications
  • Credit: 0.50hr(s)
  • AAFP, AAPA, CME, MOC
  • February 7, 2024 — 
  • February 6, 2025
  • Therapeutic Areas: Family Medicine / Primary Care
  • Location: Internet Activity Enduring
Obstructive Sleep Apnea (OSA) is a prevalent but often underestimated sleep disorder with significant implications for the health and well-being of individuals in the United States. Despite its impact on chronic diseases and healthcare costs, OSA remains underdiagnosed, leading to untreated sleep apnea and its consequences. With emerging strategies for OSA treatment, it’s crucial for healthcare providers to stay informed about the latest clinical evidence shaping the treatment landscape.
Access Course
Scroll to Top